Highly Reputed Clinical Research Organisation based in Mumbai for Full Buyout
Email
Phone
Google
LinkedIn
Facebook
About Business
BA/BE, Clinical Trials and Biologics testing services
Clientele type
Top-tier global clients. 10 of the top 15 generic drug makers globally
Premises
Three delivery centres in India with state-of-the-art infrastructure
(428 clinical beds, 37 LCMS/MS machines)
Asking Price Includes
Whole Business
Reason
Reason can be discussed with Serious Buyer
More Details
Full service, independent contract research organization providing BA/BE, Clinical Trials and Biologics testing services
Strong presence in China. 30 clients served in China; 150 studies done for Chinese clients including 90 for CFDA;
China accounted for 32% of the Company's export revenues in FY18.
700 people team with highly qualified employees; 284 PhDs and post-graduates
Built deep, trusted relationships with Chinese clients by passing in-depth audits and providing quality service
Executed First-to-File studies, 4-way cross-over studies, complex molecule studies
Highlights
* 700+ analytical assays
* 100+ Successful audits by US FDA, WHO, EMA, ANVISA etc. (33 US FDA inspections)
* 187 clients from across the globe serviced
* 3,022 BA/BE studies done
* 1,293 pivotal studies completed for USFDA submissions
* 29 Clinical trial studies, 24 Biologics studies
Keywords
Business Exit for ₹10 Cr – 200 Cr
Structured Transition Completed in 120 Days
Credible Buyer Connections, Confidential Discussions, and Seamless Closure
Supported by Advisors with 26+ Years of Experience
